BNF presentation directory

Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.

Chapter

Reset

Active filters

Chemical substance: Cabozantinib

Presentation	Product	Chemical substance	Chapter	Items dispensed
Cabometyx 20mg tablets 0801050BRBCAAAC	Cabometyx	Cabozantinib	Malignant Disease and Immunosuppression	No data available
Cabometyx 40mg tablets 0801050BRBCABAD	Cabometyx	Cabozantinib	Malignant Disease and Immunosuppression	No data available
Cabometyx 60mg tablets 0801050BRBCACAE	Cabometyx	Cabozantinib	Malignant Disease and Immunosuppression	No data available
Cabozantinib 20mg capsules 0801050BRAAAAAA	Cabozantinib	Cabozantinib	Malignant Disease and Immunosuppression	No data available
Cabozantinib 20mg capsules and Cabozantinib 80mg capsules 0801050BRAAABAB	Cabozantinib	Cabozantinib	Malignant Disease and Immunosuppression	No data available
Cabozantinib 20mg tablets 0801050BRAAACAC	Cabozantinib	Cabozantinib	Malignant Disease and Immunosuppression	No data available
Cabozantinib 40mg tablets 0801050BRAAADAD	Cabozantinib	Cabozantinib	Malignant Disease and Immunosuppression	No data available
Cabozantinib 60mg tablets 0801050BRAAAEAE	Cabozantinib	Cabozantinib	Malignant Disease and Immunosuppression	No data available
Cometriq 20mg capsules 0801050BRBBAAAA	Cometriq	Cabozantinib	Malignant Disease and Immunosuppression	No data available
Cometriq 20mg capsules and Cometriq 80mg capsules 0801050BRBBABAB	Cometriq	Cabozantinib	Malignant Disease and Immunosuppression	No data available

Why monitor BNF codes?

Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.

Track cost pressure

Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.

Understand demand drivers

Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.